Results 361 to 370 of about 3,932,956 (396)
Some of the next articles are maybe not open access.
Lung cancer: New biological insights and recent therapeutic advances
Ca-A Cancer Journal for Clinicians, 2011Suresh S Ramalingam, Fadlo R Khuri
exaly
Studies on a Doubleheaded Protease Inhibitor from Phaseolus mungo
Journal of Plant Biochemistry and Biotechnology, 2012N. Hajela +4 more
semanticscholar +1 more source
2009
The present invention relates to a polypeptide exhibiting a protease inhibitory activity and uses of said polypeptide in methods for inhibiting, directly or indirectly, one or more proteases of the blood clotting cascade. The invention also relates to use of said polypeptide as a pharmaceutical e.g.
Nielsen, Kåre Lehmann +1 more
openaire +1 more source
The present invention relates to a polypeptide exhibiting a protease inhibitory activity and uses of said polypeptide in methods for inhibiting, directly or indirectly, one or more proteases of the blood clotting cascade. The invention also relates to use of said polypeptide as a pharmaceutical e.g.
Nielsen, Kåre Lehmann +1 more
openaire +1 more source
An NS3 protease inhibitor with antiviral effects in humans infected with hepatitis C virus
Nature, 2003D. Lamarre +27 more
semanticscholar +1 more source
NTRK fusion-positive cancers and TRK inhibitor therapy
Nature Reviews Clinical Oncology, 2018Emiliano Cocco +2 more
exaly
The evolving landscape of biomarkers for checkpoint inhibitor immunotherapy
Nature Reviews Cancer, 2019Jonathan J Havel +2 more
exaly
Appraising iniparib, the PARP inhibitor that never was—what must we learn?
Nature Reviews Clinical Oncology, 2013Joaquin Mateo +2 more
exaly
Protease inhibitors bacterial proteases and their inhibitors.
The Biochemical journal, 2008E S, DUTHIE, L, LORENZ
openaire +1 more source

